Cytoplasmic extracts from spontaneously proliferating and mitogen-activated lymphoid cells contain a protein factor called ADR (activator of DNA replication) that induces DNA synthesis in isolated quiescent nuclei. ADRcontaining preparations have proteolytic activity, as indicated by their ability to degrade fibrin in a plasminogen-independent and plasminogen-dependent manner. In addition, aprotinin, a nonspecific protease inhibitor, abrogates ADR-induced DNA synthesis in a dose-dependent fashion. Preincubation studies demonstrated that the effect of aprotinin is not due to its suppressive effects on the nuclei themselves. Other protease inhibitors such as leupeptin, p-aminobenzamidine, and N-atosyllysine chloromethyl ketone are also inhibitory, but soybean trypsin inhibitor is without effect. ADR activity can be removed from active extracts by adsorption with aprotininconjugated agarose beads and can be recovered by elution with an acetate buffer (pH 5). These findings are consistent with the interpretation that the initiation of DNA synthesis in resting nuclei may be protease dependent and, further, that the cytoplasmic stimulatory factor we have called ADR may be a protease itself.
It has been known for many years that nuclear DNA synthesis is under cytoplasmic control (1) . Using cell-free systems, a number of investigators have shown that cytoplasmic extracts from proliferating cells contain a protein(s) that can initiate nuclear DNA synthesis (2) (3) (4) (5) (6) (7) (8) (9) . We have reported such cytoplasmic intermediate(s) in spontaneously proliferating and mitogen-activated lymphoid cells (7, 8) . This factor, which we have called activator of DNA replication (ADR), is a heat-labile protein of Mr >100,000. It is not detectable in resting cells. Although it activates isolated quiescent nuclei, it has no effect on intact cells. ADR is not species specific. Furthermore, ADR appears to mediate an intracellular mitogenic signal in the interleukin 2 (IL-2) T-cell activation pathway (9) . Das (6) has described a cytoplasmic intermediate in epidermal growth factor-stimulated 3T3 fibroblasts that shares many functional and physicochemical properties with ADR. In addition, Benbow and Ford (2) reported a similar cytoplasmic stimulatory factor in early embryonic tissue. The description of ADR-like proteins in a number of cell types and experimental systems suggests a significant role for these factors in cellular proliferation and differentiation.
To our knowledge, no information is available as to the biochemical nature of ADR or the ADR-like factors in other cell types (2) (3) (4) (5) (6) . We now report that ADR preparations have proteolytic activity and that the functional activity of ADR can be significantly inhibited by aprotinin and a number of other protease inhibitors. The inhibition of ADR-induced DNA synthesis was not due to any direct effects of aprotinin on the isolated resting nuclei. Rather, the protease inhibitor appears to interact with ADR itself.
MATERIALS AND METHODS
Cell Cultures and Preparation of Cytoplasmic Extracts. MOLT-4, a spontaneously proliferating human T-cell leukemia line, was maintained as described (7) . Peripheral blood lymphocytes were obtained from young, healthy donors, isolated, cultured, and stimulated with phytohemagglutinin at 10 ,ug/ml (Sigma) as described (7) . Cytoplasmic extracts were prepared by hypotonic lysis and Dounce homogenization (7). Homogenates were centrifuged at 3000 x g for 10 min.
Supernatant was collected and adjusted to 0.1 M sucrose/10 mM KCl before ultracentrifugation at 140,000 x g for 60 min (type 65 rotor, Beckman). Partial purification of ADR was by ammonium sulfate fractionation and Amicon ultrafiltration (7) .
Preparation of Isolated Nuclei. Adult frogs (Xenopus laevis) were purchased from Nasco (Ft. Atkinson, WI). Isolated nuclei were prepared by the detergent lysis method of Benz and Strominger (10) as described (7) . Since ADR lacks species specificity (7), frog nuclei were used for the routine assay.
Assay for DNA Synthesis in Isolated Nuclei. Assays were performed in triplicate in 96-well microtiter plates (Falcon) as described (7) . Nuclei (2 x Stimulation of Lymphoblasts with IL-2. Peripheral blood lymphocytes were collected and cultured with phytohemagglutinin as described above. After 5 days, the lymphoblasts were collected and recultured at 1-1.5 x 106 cells per ml with either complete medium alone or complete medium plus 2% (wt/vol) IL-2 for another 48 hr. The cells were then collected, and cytoplasmic extracts were prepared from both cultures as described above.
Preincubation Experiments. Frog spleen nuclei were prepared as described above and were incubated with aprotinin at 250 pug/ml for 15 min at 370C. Control nuclei were incubated with nuclei buffer in a similar fashion. The nuclei were then centrifuged at 2000 x g for 10 min, recounted, and resuspended at 2 x 107 nuclei per ml with nuclei buffer. ADR was added, and DNA synthesis was measured in the usual fashion.
Assay of Serine Protease Activity. Proteolytic activity was based on the hydrolysis of 251I-labeled fibrin, coated onto tissue culture wells. Fibrinogen, free of plasminogen, was purified according to published methods (11) and radiolabeled by lactoperoxidase-catalyzed iodination as described (12, 13) . Human plasminogen was purified as described by lysine-Sepharose 4B affinity chromatography (13) . The 25I-labeled fibrinogen was placed in tissue culture wells (10 ,4g/cm2, 500-700 cpm/kkg) and dried at 450C for 72 hr.
Following drying, the 125I-labeled fibrinogen-coated wells were incubated at 37TC for 2.5 hr in medium supplemented with fetal bovine serum. Thrombin and other factors contained in the serum converted 251I-labeled fibrinogen to insoluble 1251-labeled fibrin. Each well was washed twice with PBS (0.01 M, pH 7.4) and washed an additional time just prior to the assay with 0.1 M Tris-HCl (pH 8.1). The assay incubation mixture contained 0.02% Triton X-100, 1 ml of 0.1 M Tris HCl (pH 8.1), an aliquot of ADR, and where indicated, 5-10 ,g of purified plasminogen. The radioactivity released from the wells was determined by direct y counting.
Adsorption of ADR with Agarose Beads. Slurries containing plain agarose beads, soybean trypsin inhibitor (SBTI)-conjugated agarose beads, or aprotinin-conjugated agarose beads (all from Sigma) were centrifuged at 170 x g for 10 min and washed three times with the hypotonic extract buffer. Ovalbumin (10 mg/ml) (Sigma) was mixed with the beads at a ratio of 2 ml of ovalbumin/1 ml of packed beads. This was done to prevent nonspecific sticking of protein to the agarose itself. The beads were incubated at 37°C for 30 min on a rocker platform (Lab Line, Melrose Park, IL). The beads were tinsed on filter paper five times with extract buffer and resuspended in extract buffer. The beads were centrifuged at 170 x g for 10 min. Supernatant was removed, and MOLT-4 cytoplasmic extract was added at a ratio of 2 ml of extract/1 ml of packed beads. The beads were then incubated at 37°C for 30 min on a rocker platform. The beads were centrifuged at 170 x g for 10 min. The supernatant was removed and assayed for ADR activity as described above. The beads were stored overnight at 4°C with a small amount of extract buffer to prevent drying.
Elution of ADR from Agarose Beads. A modification of the method of Baugh and Travis (14) was used. Syringes (5 ml) were packed with scrubbed nylon wool (Fenwal Laboratories, Deerfield, IL) up to the 1-ml mark and washed with extract buffer. Aprotinin-agarose and plain agarose beads prepared from adsorption assays were added to separate columns and allowed to settle. Each column was washed extensively with extract buffer before the addition of elution buffer (0.05 M sodium acetate, pH 5.0/0.4 M NaCl). Eight 1-ml fractions were collected from each column and dialyzed. Protein content was estimated spectrophotometrically using a Coomassie blue dye-binding procedure ( dine were tested for the ability to inhibit ADR activity. The concentration of the protease inhibitors ranged from 31.5 to 250 tkg/ml. Fig. 3 demonstrates the inhibition profile of these various agents. The doses of aprotinin, TLCK, and leupeptin required to achieve 50% inhibition of ADR activity in this experiment were very similar (=25 tkg/ml) whereas paminobenzamidine exhibited significantly less inhibitory effect (ED50 = =200 Ag/ml).
Failure to Inhibit ADR-Induced DNA Synthesis by Preincubation of Resting Nuclei with Aprotinin. To determine whether aprotinin may be directly affecting the nuclei themselves, quiescent frog nuclei were prepared in the usual manner and preincubated with aprotinin at 250 pug/ml. This dose was used because it had been shown to cause complete inhibition of DNA synthesis when added to nuclei and MOLT-4 extracts in mixed cultures. After 15 min, the nuclei were washed, cultured with ADR, and assayed for DNA synthesis in the usual fashion. As shown in Table 1 , the nuclei were unimpaired in their ability to respond to ADR after pretreatment with aprotinin.
Adsorption of ADR Activity on Aprotinin-Conjugated Agarose Beads. We next tested the ability of insolubilized Fig. 5 was 0.475 Ag/ml, 0.475 ,ug/ml, 0.325 ttg/ml, and 0.75 Ag/ml, respectively. There was no detectable protein in fractions 5-8 or in any of the eight fractions eluted from the plain agarose columns. We were able to achieve a 4-fold, 11-fold, 13-fold, and 50-fold increase in specific ADR activity, respectively, in fractions 1-4 eluted from the aprotininagarose column, as compared to the starting preparation. DISCUSSION Proteolytic enzymes may be important in the regulation of cell proliferation (15) . Several studies have demonstrated direct mitogenic effects of proteases on intact cells (16) (17) (18) . Moreover, protease inhibitors can suppress cellular proliferation (19) (20) (21) (22) (23) . All these studies involve effects on whole cells, with proteolytic activation of cell surface membranes.
In the present study, we have obtained evidence supporting a role for cellular proteases in the intracellular regulation of cell growth. We first showed that the cytoplasmic factor ADR that induces DNA synthesis in isolated quiescent nuclei is associated with proteolytic activity. However, because ADR has not yet been purified to homogeneity, it was necessary to perform additional experiments making use of a battery of protease inhibitors. Using a cell-free assay, we have demonstrated that the induction of DNA synthesis in isolated quiescent nuclei by ADR can be abrogated by the protease inhibitors aprotinin, TLCK, p-aminobenzamidine, and leupeptin, but not SBTI. The inability of aprotinin to inhibit ADR-induced DNA synthesis when preincubated with resting nuclei suggests that this agent has no direct suppressive or toxic effects on the nuclei themselves. The fact that we could adsorb ADR activity from active MOLT-4 extracts with aprotinin-conjugated agarose beads demonstrates that the ADR-nucleus interaction is protease dependent. Most important, the ability to elute ADR activity from these columns means that aprotinin is interacting with ADR itself.
Aprotinin is a serine esterase inhibitor that reversibly inhibits a variety of proteolytic enzymes, including trypsin, chymotrypsin, plasmin, kallikrein, and intracellular proteases (24) . As indicated above, the ability of ADR to bind to aprotinin-agarose beads and the elution of ADR from such beads strongly suggests that ADR is a protease. The direct demonstration that ADR preparations exhibit proteolytic activity supports this contention. The ability of TLCK to interfere with ADR activity is also consistent with this interpretation, but also raises another possibility that TLCK can also react with protein kinases (25, 26) , and our preparations of ADR also exhibited tyrosine kinase activity. However, neither aprotinin nor the other protease inhibitors used in this study have been reported to have anti-tyrosine A role for intracellular proteases in lymphocyte stimulation has been suggested by several investigators. Ku et al. (22) reported the presence of an intracellular, arginine-specific serine enzyme that is synthesized in higher quantities following mitogenic stimulation of B cells. Furthermore, Nishizawa et al. (27) and Kishimoto et al. (28) reported that during the activation of B lymphocytes by anti-immunoglobulin, a membrane-bound serine protease splits a cytoplasmic precursor protein into an active 45-kDa factor. This active cytoplasmic factor induces the phosphorylation of nonhistone nuclear proteins (29, 30) . Our results, however, differ from their findings in that the active cytoplasmic stimulatory factor in our system appears to be the protease itself.
Furthermore, neither of these studies demonstrated that the appearance of protease activity was functionally related to DNA synthesis itself; thus, it is not clear whether these proteins would be capable of inducing DNA replication in a cell-free system.
The mechanism by which protease inhibitors block nuclear DNA synthesis is presently unclear. It has been suggested that protease inhibitors suppress cell growth by inhibiting protein synthesis directly (31) . However, Grayzel et al. (20) demonstrated that TLCK significantly inhibits lymphocyte transformation without a major effect on protein synthesis. The results from our studies, which utilize preformed nuclear activation factors, would also rule against this possibility.
Another role for proteases in the activation of cells for proliferation has been postulated by Brown et al. (32, 33 Regardless of underlying mechanism, the results presented here, in conjunction with our previous findings (7-9), suggest that proteases or enzymes with similar active sites are important in the transduction sequence by which exogenous mitogens (phytohemagglutinin, Con A) or growth factor (IL-2) induce lymphocyte proliferation. From the nature of the detecting assay for ADR, which involves its effect on DNA synthesis in isolated quiescent nuclei, it is clear that it is at the terminal end of the chain of events leading from cell surface alterations to nuclear activation. Future studies require not only the elucidation of its precise mechanism of action, but also an attempt to understand how these late events are related to early signals such as cell surface receptor autophosphorylation, ionic fluxes, and alterations in cyclic nucleotide levels.
